Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

Table 1 Demographic, clinical and laboratory parameters of patients with cryptogenic cirrhosis and non-cryptogenic cirrhosis

Variable	Cryptogenic (n = 134, %)	Non-cryptogenic (n = 134, %)	P
Sex (female)	83 (62)	75 (56)	0.32
DM	53 (40)	30 (22.4)	0.013
HBP	24 (18)	14 (10.4)	0.08
Hyperuricemia	13 (10)	2 (1.5)	0.003
Dyslipidemia	72 (54)	8 (6)	< 0.001
Overweight (BMI > 25)	103 (77)	106 (79)	0.65
Obesity (BMI > 30)	22 (16.4)	11 (8.2)	0.04
MS	39 (29.1)	8 (6)	< 0.001
Age (yr, mean ± SD)	54.6 ± 14.3	56.8 ± 11.4	0.15
BMI (mean ± SD)	27 ± 4.6	26 ± 4	0.22
ALT (U/L, mean ± SD)	52.5 ± 59	57.5 ± 33	0.72
AST (U/L, mean ± SD)	67.1 ± 60	77.8 ± 46	0.19

DM: Diabetes mellitus; HBP: High blood pressure; BMI: Body mass index (calculated as patient’s body weight divided by the square of the height expressed in kg/m²); MS: Metabolic syndrome.